Oxytocin and group therapy for schizophrenia
Treatments studied
Part of Mental health clinical trials.
This trial tests whether adding oxytocin (a hormone that helps with social bonding) to group therapy can improve symptoms and social functioning in people with schizophrenia. It compares two different doses of oxytocin to see which works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia or a related condition (like schizoaffective disorder).
- You have mild to moderate symptoms (not severe).
- You speak German fluently (native or near-native).
- Your psychiatric medications have been stable (no changes) for at least 2 weeks.
- You are not currently in a severe psychotic episode, not suicidal, and not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a yoga-based group program can help people with schizophrenia spectrum disorders feel better. It's designed for outpatients who are stable enough to participate in group therapy.
This trial tests whether oxytocin, a hormone that helps with social bonding and stress, can improve anxiety or emotional awareness in people with central diabetes insipidus (a condition where the body can't regulate water balance). It may be a good fit if you have high anxiety or trouble identifying your feelings.
This trial studies whether a structured group yoga program can help people who are currently receiving care for schizophrenia-spectrum disorders. It focuses on patients with low-to-moderate current psychosis and aims to add a supportive therapy alongside usual treatment.
This trial studies whether oxytocin, given alongside structured psycho-educational support, can be safe and feasible in helping children with autism and moderate-to-severe intellectual disability who have challenging behaviors. It focuses on whether the added treatment can work without unacceptable side effects.
This Phase 2 study tests whether giving oxytocin (a hormone sometimes studied for social and bonding effects) helps patients and therapists become more “physiologically synchronized” during inpatient psychiatric care. It compares responses in patients and therapists to see if this change is measurable and potentially helpful.
This trial tests if combining a gentle brain stimulation technique (tACS) with talk therapy (CBT for psychosis) can help reduce symptoms in people with schizophrenia. You would keep taking your usual medications throughout the study.
Hear when a new Schizophrenia Spectrum Disorders (SSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.